RepliCel Life Sciences EPS
What is the EPS of RepliCel Life Sciences?
The EPS of RepliCel Life Sciences, Inc. is -0.01
What is the definition of EPS?
Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. It is adjusted for dilution and calculated over trailing twelve months.
ttm (trailing twelve months)
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS of companies in the Health Care sector on TSXV compared to RepliCel Life Sciences
What does RepliCel Life Sciences do?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Companies with eps similar to RepliCel Life Sciences
- Respiri has EPS of -0.01
- Carespan Health Inc has EPS of -0.01
- China Environmental Technology and Bioenergy has EPS of -0.01
- Aurora Solar Technologies has EPS of -0.01
- Tanzanian Gold has EPS of -0.01
- Synertec has EPS of -0.01
- RepliCel Life Sciences has EPS of -0.01
- Ming Lam has EPS of -0.01
- GME Resources has EPS of -0.01
- Super Strong has EPS of -0.01
- Fintech Select has EPS of -0.01
- Summit Ascent has EPS of -0.01
- New City Development has EPS of -0.01